Evidence map›Paper›PMID 17470647›Full record

ArticleAntimicrobial agents and chemotherapy2007

Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.

Marie-Frédérique Lartigue, Catherine Zinsius, Aline Wenger, Jacques Bille, Laurent Poirel, Patrice Nordmann

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Multiplex PCR assay for the rapid detection ofJournal of medical microbiology · 2025
    Article
  3. Article
  4. ESBL- and Carbapenemase-ProducingMicroorganisms · 2023
    Article
  5. Urban Pigeons (Antibiotics (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Marie-Frédérique LartigueService de Bactériologie-Virologie, Hôpital de Bicêtre, 78 rue du Général Leclerc, Bicêtre, France.
Catherine Zinsius
Aline Wenger
Jacques Bille
Laurent Poirel
Patrice Nordmann
Assistance Publique – Hôpitaux de Paris · FRUniversité Paris-Sud · FRUniversity Hospital of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The epidemiology of clavulanic acid-inhibited extended-spectrum beta-lactamases (ESBLs) was investigated among infection-associated enterobacterial isolates at the University Hospital in Lausanne, Switzerland, from January 2004 to June 2005. Out of 57 nonrepetitive ESBL producers (prevalence rate of 0.7%), 45 produced CTX-M-like ESBLs. CTX-M enzymes were mostly from clonally nonrelated Escherichia coli isolates, from urinary infections and community-acquired infections. Pediatric patients (20 out of 57) accounted for a large number of CTX-M producers. CTX-M-15 was the most frequent CTX-M-type enzyme. The plasmid-located bla(CTX-M) genes were associated with either ISEcp1 or ISCR1 insertion sequences. This study is the first published report of CTX-M-type beta-lactamases in Switzerland.

Indexed as

Anti-Bacterial Agentsbeta-LactamasesCommunity-Acquired InfectionsEnterobacteriaceaeEnterobacteriaceae InfectionsEscherichia coliHospitals, UniversityHumansMicrobial Sensitivity TestsMolecular EpidemiologyPolymerase Chain ReactionPrevalenceSwitzerlandAnti-Bacterial Agentsbeta-lactamase CTX-M-15beta-Lactamases

Identifiers

PMID17470647
PMCPMC1932552
OpenAlexW2109834617

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.